← Leaderboards
Jacob M Berlin
Beckman Research Institute/City Of Hope
$850,104
Attributed
$1,700,208
Total exposure
2
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $388.9K · FY2013–18$500K$375K$250K$125K$0
'13
'14
'15
'16
'17
'18
Funding mix
By agency
NIH$1,700,208 · 2
By mechanism
R01$1,235,202 · 1
R21$465,006 · 1
Top collaborators
- Karen S Aboody4 shared
- Behnam Badie2 shared
Most similar at Beckman Research Institute/City Of Hope
Same institution · by research overlap
- Terence Marques Williams$5,994,391
- Behnam Badie$11,237,051
- Joseph Kim$727,770
Others in their field
Top investigators on “In Vitro”
- David Heimbrook · Leidos Biomedical Research, Inc.$553,787,942
- Leonard Freedman · Leidos Biomedical Research, Inc.$310,441,779
- Mark S Klempner · Tufts Medical Center$128,021,180
- Florian Krammer · Icahn School Of Medicine At Mount Sinai$104,723,856
- Lynn Briscoe · Leidos Biomedical Research, Inc.$94,686,873
- Dennis R. Burton · Scripps Research Institute$79,204,175
Research focus
In VitroMalignant NeoplasmsPreventTumorSiteNanoparticleIn VivoNerve Stem CellToxic EffectSurfaceStrokeCellsBrainPropertyGliomaPublic Health RelevanceBehaviorDrug TargetingDrug Delivery SystemsAdverse EffectsDrug EfficacyEncapsulatedChemotherapyCell Therapy
Grant awards (6)
Stem Cell/Nanoparticle Constructs for Targeted Ovarian Cancer Therapy$68,577
R01 · FY2018 · CA · contact PI
Stem Cell/Nanoparticle Constructs for Targeted Ovarian Cancer Therapy$388,875
R01 · FY2017 · CA · contact PI
Stem Cell/Nanoparticle Constructs for Targeted Ovarian Cancer Therapy$388,875
R01 · FY2016 · CA · contact PI
Stem Cell/Nanoparticle Constructs for Targeted Ovarian Cancer Therapy$388,875
R01 · FY2015 · CA · contact PI
Dynamic Magnetic Targeting of Activated Brain Macrophages for Glioma Therapy$195,117
R21 · FY2014 · NS
Dynamic Magnetic Targeting of Activated Brain Macrophages for Glioma Therapy$269,889
R21 · FY2013 · NS